Negative axillary ultrasound can lead to breast biopsy omission

Many women with early-stage HR+HER2- breast cancer and a negative presurgical axillary ultrasound can skip sentinel lymph node biopsy, a study presented April 11 at the American Society of Breast Surgeons Annual Meeting in Orlando, FL, found. In his talk, Andreas Giannakou, MD, from Brigham & Women’s Hospital and Harvard Medical School in Boston showed results suggesting that nodal disease burden and oncologic outcomes among women in a real-world setting are similar to criteria in the Sentinel Node vs. Observation After Axillary UltraSound (SOUND) trial. “Although our follow-up is limited, oncologic outcomes are excellent and similar to the sentinel lymph node biopsy arm of the SOUND trial,” Giannakou said in a pre-meeting press conference.Andreas Giannakou, MD, from Brigham & Women’s Hospital and Harvard Medical School presents research highlighting how many women with early-stage HR+HER2- breast cancer and a negative presurgical axillary ultrasound can skip sentinel lymph node biopsy. Results from the SOUND trial were published in 2023, showing that omitting axillary surgery could be an option for women with small breast cancers and a negative result on ultrasound of the axillary lymph nodes. While the trial included all breast cancer subtypes, the Giannakou team focused on examining nodal disease burden and oncologic outcomes among women with cT1N0 HR+HER2- negative breast cancer who would have been eligible for the SOUND trial. The study included 510 women who...
Source: AuntMinnie.com Headlines - Category: Radiology Authors: Tags: Ultrasound Womens Imaging Source Type: news